Biotechnology Expert · Molecular and Cellular Biologist

Dr. Baranyi earned his degree as a certified biologist from the
University of Szeged in 1982,
and later obtained his PhD in
tumor immunology and cell biology at the same institution
in 1986.

He spent several years in Japan as a visiting researcher and
subsequently became a Professor at the Nagoya University School of Medicine,
where he delivered postgraduate lectures in
surgery, immunology, and protein structure.
During this period, he studied parallel programming at the
Toyohashi University of Technology, developing protein-structure
analysis applications and novel algorithms.
Using these methods, he successfully designed a large number of biologically
active peptides, including one that enabled the development of the
first artificial HIV resistance gene.

Dr. Baranyi was later invited to the
Walter Reed Army Institute of Research in Washington, D.C.,
where he conducted research on
artificial blood development, cardiovascular science, and vaccine development.
His scientific publications appeared in leading international journals,
including two landmark papers in Nature Medicine,
describing a novel structural element of proteins and a
previously unknown and surprising function of immunoglobulins.

He continued his research and development work in the biotechnology industry,
achieving world-class results in
next-generation recombinant vaccine development,
recombinant protein production, and bioreactor design.
He became a recognized expert in gene therapy technologies and
participated in the first successful clinical trials of CAR-T cancer therapy,
as well as in the development of next-generation CAR technologies.

Dr. Baranyi is currently the Founder and Chief Executive Officer (CEO)
of Kelsius Systems Group, where he is working on the
implementation of his latest patents, including applications related to
spider silk–based technologies.
In collaboration with the University of Szeged, he is also
developing a novel therapeutic approach aimed at
mitigating cytokine storm syndromes.